Hepatitis B virus genotypes and the response to lamivudine therapy;Wystȩpowanie genotypów wirusa zapalenia wa̧troby typu B (HBV) oraz ich wpływ na skuteczność leczenia lamiwudyna̧

Polskie Archiwum Medycyny Wewnetrznej

Volumn 114, Issue 6, 2005, Pages 1190-1199

  Zalewska, Małgorzata ^a   Domagała, Małgorzata ^a   Simon, Krzysztof ^a   Gładysz, Andrzej ^a  

^a AM   (Poland)

Author keywords

Chronic hepatitis B; HBV DNA; HBV genotype; HBV infection; Lamivudine

Indexed keywords

LAMIVUDINE; ANTIVIRUS AGENT; HEPATITIS B ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; ADULT; BLOOD; GENETICS; LIVER FUNCTION TEST; MIDDLE AGED; VIROLOGY; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 33645999961     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Moriya T., Kuramoto I.K., Yoshizawa H., Holland P.V.: Distribution of hepatitis B virus genotypes among American blood donors determined with a preS2 epitope enzyme-linkes immunosorbent assay kit. J. Clin. Microbiol., 2002, 40, 877.
2. Locarini S.A.: Clinical relevance of viral dynamics and genotypes in hepatitis B virus. J. Gastroenterol. Hepatol., 2002, 17, 322.
3. Aruz-Ruiz P., Norder H., Robertson B.H., Magnius L. O.: Genotype H: a new Amerindian genotype of hepatitis B Virus revealed in Central America. J. Gen. Virol., 2002, 83, 2059.
4. Kidd-Ljunggren K., Miyakawa Y., Kidd A.H.: Genetic variability in hepatitis B viruses. J. Gen. Virol., 2002, 83, 1267.
5. Magnius L.O., Norder H.: Subtypes, genotypes and molecular epidemiology of hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology, 1995, 38, 24.
6. Lindh M., Andersson A.S., Gusdal A.: Genotypes, nt 1858 variants and geographic origin of hepatitis B virus -large-scale analysis using a new genotyping method. J. Infect. Dis., 1997, 175, 1285.
7. Chu C.J., Lok A.S.F.: Clinical significance of hepatitis B virus genotype. Hepatology, 2002, 35, 1274.
8. Orito E., Mizokami M. : Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Intervirology, 2003, 46, 408.
9. Zhou D.Y., Lin L.Y., Wang H., Huang J.S.: The relationship between HBV lamivudine resistance and HBV genotypes or basic core promoter mutations. Hepatobiliary Pancreat. Dis. Int., 2003, 2, 85.
10. Gandhe S.S., Chanda M.S., Arankalle V.A.: Hepatitis B virus genotypes and serotypes in western India: lack of clinical significance. J. Med. Virol., 2003, 69, 324.
11. Suzuki S., Sugauchi F., Orito E. i wsp: Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the Cote d'Ivoire: complete genome sequence and phylogenetic relatedness of HBV genotype E. J. Med. Virol., 2003, 69, 459.
12. Odemuyiwa S.O., Mulders M.N., Oyedele O.I. i wsp.: Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa. J. Med. Virol., 2001, 65, 463.
13. Thomas H.C, Scully L.J., Lever A.M.L., Yap I., Pignatelli M.: A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates. Infection, 1987, 15,26.
14. Kao J.H., Wu N.H., Chen P.J., Lai M.Y., Chen D.S.: Hepatitis B genotypes and the response to interferon therapy. J. Hepatol., 2000, 33, 998.
15. Erhardt A., Reincke U., Blondin D. i wsp.: Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology, 2000, 31, 716.
16. Zollner B., Petersen J., Schroter M., Laufs R., Schoder V., Feucht H.H.: 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet, 2001, 357, 934.
17. Westland C., Delaney W. 4th, Yang H. i wsp.: Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil. Gastroenterology, 2003, 125, 107.
18. Bielawski K.P., Dybikowska A., Lisowska-Charmuszko U., Stalke P. i wsp.: Distribution of HBV genotypes and mutants among hepatitis B infected patients from northern Poland. Int. J. Mol. Med., 2004, 14, 301.
19. Krekulova L., Rehak V., Da Silva Filho H.P., Zavoral M., Riley L.W.: Genotypic distribution of hepatitis B virus in the Czech Republic: a possible association with modes of transmition and clinical outcome. Eur. J. Gastroenterol. Hepatol., 2003, 15, 1183.
20. Kapke G.F., Watson S., Sheffler S., Hunt D., Frederick C.: Comparison of Chiron Quan-tiplex branched DNA (bDNA) assay and the Abbott Genostics Hybridization Assay for quantification of hepatitis B viral DNA. J. Viral. Hep., 1997, 4, 67.
21. Mayerat C., Mantegani A., Frei P.C.: Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J. Viral. Hepat., 1999, 6, 299.
22. Perez-Olmeda M.,Nunez M., Garcia-Samaniego J., Rios P., Gonzalez-Lahoz J., Soriano V.: Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications. AIDS Res. Hum. Retroviruses, 2003, 19, 657.
23. Lindh M., Horal P., Norkrans G.: Acute hepatitis B in Western Sweden genotypes and transmission routes. Infection, 2000, 28, 161.
24. Van Steenbergen J.E., Niesters H.G., Op de Coul E.L. i wsp.: Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997. J. Med. Virol., 2002, 66, 159.
25. Swenson P.D., Van Geyt C., Alexander E.R. i wsp.: Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA. J. Med. Virol., 2001, 64, 305.
26. Thakur V., Guptan R.C., Kazim S.N. i wsp.: Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J. Gastroenterol. Hepatol., 2002, 17, 165.
27. Hussain M., Chu C.J., Sablon E., Lok A.S.F.: Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core pro-moter variants. J. Clin. Microbiol., 2003, 41, 3699.
28. Hannoun C., Krogsgaard K., Horal P., Lindh M. and the Interpreted Trial Group: Geno-type mixtures of hepatitis B virus in patients treated with interferon. J. Infect. Dis., 2002, 186,752.
29. Osiowy C., Giles E.: Evaluation of INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype. J. Clin. Microbiol., 2003, 41, 5473.
30. Bowyer S.M., Sim J.G.: Relationship within and between genotypes of hepatitis B virus at points across the genome: footprints of recombination in certain isolates. J. Gen. Virol., 2000, 81, 379.
31. Kao J.H.: Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology, 2003, 46, 400.
32. Ishikawa K., Koyama T., Masuda T.: Prevalence of HBV genotypes in asymptomatic carrier residents and their clinical characteristics during long-term follow-up: the relevance to changes in the HBeAg/ anti-HBe system. Hepatol. Res., 2002, 24, 1.
33. Chanj H.L., Wang M.L., Hui A.Y., Hung L.C., Chan F.K., Sung J.J.: Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients. J. Cin. Microbiol., 2003, 41, 1277.
34. Yuen M.F., Tanaka Y., Lai C.L.: Hepatitis B genotypes in chronic hepatitis B and lamivudine therapy. Intervirology, 2003, 46, 373.
35. Yuen M.F., Wong D.K., Sablon E. i wsp.: Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine. Antivir. Ther., 2003, 8, 531.
36. Zollner B., Petersen J., Puchhammer-Stockl E. i wsp.: Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology, 2004, 39, 42.